Sociodemographic and clinicopathologic features associated with rapid relapse in triple-negative breast cancer: a Swedish nationwide registry-based study.
8 affiliations
- 1Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
- 2Sahlgrenska Center for Cancer Research, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
- 3Department of Surgery, Skaraborg Hospital, Region Västra Götaland, Skövde, Sweden. [email protected].
- 4Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. [email protected].
- 5Department of Oncology, Sahlgrenska University Hospital, Region Västra Götaland, Gothenburg, Sweden.
- 6Department of Oncology, Borås Hospital, Region Västra Götaland, Borås, Sweden.
- 7Department of Clinical Pathology, Sahlgrenska University Hospital, Region Västra Götaland, Gothenburg, Sweden.
- 8Department of Surgery, Sahlgrenska University Hospital, Region Västra Götaland, Gothenburg, Sweden.
Abstract
Purpose
To characterize clinicopathologic, treatment-related, and sociodemographic factors associated with rapid versus late relapse in triple-negative breast cancer (TNBC), and to evaluate how relapse timing influences metastatic patterns and survival outcomes.Methods
Using linked Swedish population-based registers, we conducted a retrospective cohort study of women diagnosed with non-metastatic TNBC between 2007 and 2021. Patients were classified into three groups based on time to distant relapse or death: rapid relapse (rrTNBC; ≤24 months), late relapse (lrTNBC; >24 months), or event-free at last follow-up. Tumor characteristics, comorbidity, treatments, and sociodemographic variables were compared across groups. Multivariable logistic regression and survival outcomes were assessed. Sensitivity analyses restricted to healthcare regions with complete relapse data were performed.Results
Among 8,298 patients, 15% experienced rrTNBC, 18% lrTNBC, and 67% remained event-free. rrTNBC was associated with older age, larger tumors, nodal involvement, advanced stage, and a higher frequency of visceral and multi-organ metastases. Patients with rrTNBC were less likely to receive adjuvant systemic therapy or radiotherapy and more likely to undergo mastectomy. Sociodemographic disparities were observed, with rrTNBC more frequent among patients who were single or widowed, lower educated, or had lower household income. Survival outcomes were substantially worse for rrTNBC compared with lrTNBC and event-free patients.Conclusions
Rapid relapse defines a particularly vulnerable TNBC population characterized by aggressive tumor biology, early dissemination, inferior survival, and sociodemographic disadvantage, while lrTNBC represents an intermediate phenotype with delayed disease progression. Distinguishing rrTNBC from lrTNBC may improve risk stratification, guide treatment decisions, and support more personalized follow-up strategies.
Related
- Exploratory Analysis of Age-Associated Somatic Mutation Patterns and Clinicopathologic Features in Endometrial Cancer
- Clinicopathologic Features and Diagnostic Challenges of Mycophenolate Mofetil-Associated Enterocolitis in Lung Transplant Recipients
- Myxoid dermatofibrosarcoma protuberans of the foot: Clinicopathologic and dermatoscopic features
- False-negative HHV-8 immunohistochemistry in Kaposi sarcoma: Clinicopathologic correlation leading to diagnosis of occult chronic lymphocytic leukemia
- Knowledge of gestational diabetes mellitus and its sociodemographic determinants among pregnant women in Bangladesh: a nationwide facility-based cross-sectional study.
BibTeX
@article{sarathchandra2026sociodemographic,
title = {{Sociodemographic and clinicopathologic features associated with rapid relapse in triple-negative breast cancer: a Swedish nationwide registry-based study.}},
author = {Sithumini Sarathchandra and Jenny Nyqvist-Streng and Elin Sahlberg and Zakaria Einbeigi and Khalil Helou and Anikó Kovács and Slavica Janeva and Per Karlsson and Toshima Z Parris},
journal = {Breast cancer research and treatment},
year = {2026},
month = oct,
doi = {10.1007/s10549-026-08115-z},
url = {https://europepmc.org/article/MED/42955423},
note = {CC BY},
}
RIS
TY - JOUR
TI - Sociodemographic and clinicopathologic features associated with rapid relapse in triple-negative breast cancer: a Swedish nationwide registry-based study.
AU - Sithumini Sarathchandra
AU - Jenny Nyqvist-Streng
AU - Elin Sahlberg
AU - Zakaria Einbeigi
AU - Khalil Helou
AU - Anikó Kovács
AU - Slavica Janeva
AU - Per Karlsson
AU - Toshima Z Parris
PY - 2026
DA - 2026/10/28
JO - Breast cancer research and treatment
DO - 10.1007/s10549-026-08115-z
UR - https://europepmc.org/article/MED/42955423
AB - Purpose To characterize clinicopathologic, treatment-related, and sociodemographic factors associated with rapid versus late relapse in triple-negative breast cancer (TNBC), and to evaluate how relapse timing influences metastatic patterns and survival outcomes.Methods Using linked Swedish population-based registers, we conducted a retrospective cohort study of women diagnosed with non-metastatic TNBC between 2007 and 2021. Patients were classified into three groups based on time to distant relapse or death: rapid relapse (rrTNBC; ≤24 months), late relapse (lrTNBC; >24 months), or event-free at last follow-up. Tumor characteristics, comorbidity, treatments, and sociodemographic variables were compared across groups. Multivariable logistic regression and survival outcomes were assessed. Sensitivity analyses restricted to healthcare regions with complete relapse data were performed.Results Among 8,298 patients, 15% experienced rrTNBC, 18% lrTNBC, and 67% remained event-free. rrTNBC was associated with older age, larger tumors, nodal involvement, advanced stage, and a higher frequency of visceral and multi-organ metastases. Patients with rrTNBC were less likely to receive adjuvant systemic therapy or radiotherapy and more likely to undergo mastectomy. Sociodemographic disparities were observed, with rrTNBC more frequent among patients who were single or widowed, lower educated, or had lower household income. Survival outcomes were substantially worse for rrTNBC compared with lrTNBC and event-free patients.Conclusions Rapid relapse defines a particularly vulnerable TNBC population characterized by aggressive tumor biology, early dissemination, inferior survival, and sociodemographic disadvantage, while lrTNBC represents an intermediate phenotype with delayed disease progression. Distinguishing rrTNBC from lrTNBC may improve risk stratification, guide treatment decisions, and support more personalized follow-up strategies.
SN - 0167-6806
SN - 1573-7217
ER -